Switzerland

Swiss startup Hedera Dx secures €15M to expand access to precision oncology
Swiss healthtech startup Hedera Dx has secured €15 million in a Series A funding round to scale its precision oncology platform, designed to help hospitals offer advanced cancer diagnostics and treatments.

The best Articles in our Network